Thumb Arthritis (CMC Basal Joint) in NYC: Why Your Grip Hurts and How Regenerative Treatment Can Delay Surgery

Few forms of arthritis interfere with daily life as quickly as thumb arthritis. The thumb carpometacarpal (CMC) joint — often called the basal joint — sits at the base of the thumb where the metacarpal meets the trapezium bone of the wrist. It carries load every time you open a jar, turn a key, pinch a coffee cup lid, hold a phone, or grip a subway pole. When its cartilage wears down, pinch becomes painful and weak, and patients start avoiding tasks they used to do without thinking.

At Regen Health Physicians, Dr. Ajit Dhaliwal evaluates thumb CMC arthritis in patients across New York City and Salt Lake City, with a focus on precise diagnosis and non-surgical, regenerative options for patients who are not ready for joint reconstruction. This guide explains why the CMC joint fails, how it is staged, which treatments have evidence behind them, and what a realistic regenerative protocol looks like.

Why the Thumb CMC Joint Wears Out First

The CMC joint is a saddle joint: two curved surfaces that fit together like a rider on a saddle. That geometry gives the thumb its remarkable range — flexion, extension, abduction, and opposition — but it also means stability depends almost entirely on soft tissue rather than bone architecture. The volar (anterior) oblique ligament, often called the beak ligament, is the primary restraint.

Two facts explain the joint's vulnerability:

• Load amplification. Biomechanical studies estimate that the CMC joint experiences roughly 10 to 12 times the force applied at the thumb tip during a firm pinch. A 5-pound pinch can translate to 50 pounds or more of joint reaction force.
• Ligament laxity precedes cartilage loss. When the beak ligament stretches — from repetitive load, hormonal influences on collagen, or generalized hypermobility — the metacarpal base begins to slide dorsally and radially. That shear, not simple compression, is what abrades cartilage over years.

This is why thumb arthritis is disproportionately common in women over 40, in patients with hypermobility, and in people whose work or hobbies involve sustained pinch: writers, hair stylists, dentists, massage therapists, musicians, chefs, and anyone who spends hours on a phone or trackpad.

Symptoms: What Patients Actually Describe

Thumb CMC arthritis rarely announces itself as "arthritis." Patients describe:

• Aching or burning pain at the base of the thumb, on the palm side of the wrist crease, worse with pinch or twisting
• Weakness opening jars, using scissors, turning a key or doorknob, or wringing out a cloth
• Pain when writing or holding a pen for more than a few minutes
• A visible bump or squared-off appearance at the thumb base in later stages
• Grinding, clicking, or a sense of instability with side-to-side thumb motion
• Morning stiffness that eases within 20 to 30 minutes

Pain is often mislocalized. Patients frequently believe the problem is in the wrist, and some are told they have carpal tunnel syndrome or tendonitis. The distinction matters, because the treatments differ completely.

Getting the Diagnosis Right

Several conditions cause pain at the thumb base and radial wrist, and more than one can be present at the same time:

| Condition | Distinguishing feature | |---|---| | CMC arthritis | Tender directly over the joint; positive grind test; pain reproduced by axial load plus rotation | | De Quervain's tenosynovitis | Tenderness over the first dorsal compartment, 1 to 2 cm proximal to the joint; positive Finkelstein test | | Scaphotrapeziotrapezoid (STT) arthritis | Tenderness slightly distal to the scaphoid, often coexists with CMC arthritis | | Carpal tunnel syndrome | Numbness and tingling in thumb, index, middle fingers; night symptoms; no focal joint tenderness | | Trigger thumb (flexor tenosynovitis) | Catching or locking at the thumb MCP/IP joint with a palpable nodule |

In the office, the exam includes the grind test (axial compression with rotation of the metacarpal, reproducing pain and crepitus), the shuck or shear test for instability, pinch and grip dynamometry to quantify weakness, and a check for coexisting hypermobility. Plain radiographs — a true lateral and a stress view — are used for staging (the Eaton-Littler classification, stages I through IV, ranging from joint widening and laxity to pantrapezial arthritis). Ultrasound adds real-time assessment of the ligament, joint effusion, and adjacent tendons, and it is what makes accurate injection placement possible.

Staging matters because it predicts response. Early and moderate disease — where cartilage is thinned but the joint space has not collapsed and the trapezium is uninvolved — is where regenerative and conservative treatment performs best. In stage IV disease with pantrapezial involvement and severe subluxation, surgical reconstruction is often the more honest recommendation.

Conservative Care That Actually Works

Before any injection, the foundation should be in place. Done well, this alone resolves or substantially improves a meaningful share of early cases.

Orthotic support

A hand-based thumb spica orthosis that immobilizes the CMC joint while leaving the wrist free is generally better tolerated than a long wrist-and-thumb splint, and randomized trials of CMC orthoses have shown reductions in pain and improvements in function over 6 to 12 months. Most patients do best wearing it at night plus during aggravating activities, rather than continuously — continuous use invites disuse weakness.

Targeted strengthening

The goal is not "hand exercises" but restoring dynamic stability. Emphasis goes to the first dorsal interosseous and the opponens, with deliberate avoidance of aggressive adductor loading, which increases joint shear. A hand therapist can train a "thumb-out" pinch pattern that reduces adduction moment. Trials of a stabilization-focused program have shown pain reductions comparable to or better than splinting alone.

Load and ergonomic modification

Small changes reduce cumulative joint reaction force substantially: wider-diameter pens and utensils, jar openers and electric can openers, using the palm rather than pinch to push and lift, dictation instead of typing during flares, phone holders instead of one-hand gripping, and switching a mouse for a trackball or vertical mouse.

Anti-inflammatory and metabolic groundwork

Topical NSAIDs are reasonable for flares and carry a much lower systemic risk profile than oral use. Because osteoarthritis has a documented inflammatory and metabolic component, we also assess vitamin D status, insulin resistance, and overall inflammatory load — the same principles applied throughout our chronic disease program. Patients with metabolic syndrome tend to have more symptomatic hand osteoarthritis than their radiographs alone would predict.

Regenerative Options for the CMC Joint

When conservative care plateaus, the choice is usually between a corticosteroid injection, a regenerative injection, or surgery. Here is how we think about each.

Corticosteroid injection: useful, but time-limited

An ultrasound-guided steroid injection often provides meaningful relief for 6 to 12 weeks, and in early-stage disease relief can last longer. It is a reasonable tool for breaking a severe flare or getting a patient through a deadline. The limitation is durability, and repeated injections raise legitimate concerns about cartilage and ligament quality. We generally cap frequency and avoid using steroids as a maintenance strategy.

Platelet-rich plasma (PRP)

PRP concentrates the patient's own platelets, which release growth factors — PDGF, TGF-beta, VEGF, IGF-1 — that modulate the joint's inflammatory environment and support the synovium and periarticular ligaments. In hand and thumb osteoarthritis, several randomized and comparative trials have found that PRP produces slower onset relief than corticosteroid but greater pain and function improvement at 6 and 12 months. For thumb CMC arthritis specifically, published series report durable improvement in pinch pain in early to moderate stage disease, with the least benefit where the joint space has already collapsed.

Our CMC protocol typically involves two to three ultrasound-guided injections spaced three to four weeks apart, using a small volume appropriate to a joint that holds only about 0.5 to 1 mL. Where instability is a driver, we also treat the volar oblique ligament itself rather than only the joint space — the same principle used across our regenerative medicine for joint, back and shoulder pain program.

Muse cell therapy for advanced or multi-joint disease

For patients with more advanced degeneration, multiple involved joints, or an inadequate response to PRP, we discuss Muse (Multilineage-differentiating Stress Enduring) cell therapy. Muse cells are naturally occurring pluripotent-like cells that preferentially home to damaged tissue via sphingosine-1-phosphate signaling and differentiate into the local cell type needed for repair. This is a more involved intervention with a candidacy discussion, appropriate expectations, and clear disclosure of what remains under active investigation — not a first-line treatment for an early-stage thumb.

Supportive peptide therapy

Some patients are candidates for adjunctive peptide therapy aimed at connective tissue repair and inflammatory modulation during the rehabilitation window. Peptides are supportive, not a substitute for correcting load and restoring stability, and candidacy is individualized.

What a Full Treatment Course Looks Like

A representative plan for moderate CMC arthritis:

Weeks 0 to 2 — Diagnose and unload. Exam, staging radiographs, ultrasound. Custom or off-the-shelf hand-based thumb spica for nights and aggravating tasks. Ergonomic audit of work setup. Topical anti-inflammatory for flares. Baseline pinch strength recorded.

Weeks 2 to 6 — Stabilize. Hand therapy focused on first dorsal interosseous and opponens activation, thumb-out pinch retraining, and graded loading. First ultrasound-guided PRP injection, with a 48 to 72 hour window of expected soreness and avoidance of anti-inflammatories around the injection.

Weeks 6 to 12 — Build. Second and, if indicated, third injection. Progressive strengthening, reintroduction of avoided tasks in a controlled order. Splint use tapers toward night and high-load activity only.

Months 3 to 6 — Reassess. Repeat pinch dynamometry and function scoring against baseline. Most responders continue improving through month six. If pain and pinch strength have not improved meaningfully by then, we say so directly and discuss surgical consultation rather than repeating injections indefinitely.

Honest Expectations

• Regenerative treatment for thumb CMC arthritis is best understood as pain modulation and stabilization, not cartilage regrowth. Radiographs typically do not change.
• Response is stage-dependent. Eaton stage I to III generally responds; stage IV with pantrapezial disease usually does not respond well enough to justify a course of injections.
• Onset is gradual. Expect early changes at three to four weeks and peak benefit at three to six months.
• Duration varies. Many patients get 12 to 24 months of meaningful relief and can repeat a course; some need surgery eventually. Delaying surgery is a legitimate goal in itself, particularly for younger patients.
• Compliance with load modification is the single biggest predictor of durability. An injection into a joint that keeps getting overloaded will not hold.

Who Should Consider a Surgical Consultation Instead

We recommend surgical evaluation — typically trapeziectomy with or without suspension, or arthrodesis in selected cases — when there is joint space collapse with severe subluxation and pantrapezial arthritis on imaging, fixed adduction deformity with compensatory hyperextension at the MCP joint, or persistent disabling pain and weakness after a complete conservative and regenerative course. Outcomes after trapeziectomy are generally good; the reason to try non-surgical care first is the recovery time and the fact that many patients respond without it, not because surgery is a poor option.

When to Get Evaluated Sooner

Do not wait if you have night pain that wakes you, rapidly progressive weakness, numbness and tingling suggesting nerve involvement, joint swelling with warmth or redness, or involvement of many joints with morning stiffness lasting over an hour — the last pattern raises the question of inflammatory arthritis, which needs a different workup entirely and is evaluated through our chronic disease pathway.

Getting Evaluated at Regen Health Physicians

Dr. Dhaliwal's approach to thumb arthritis starts with a precise diagnosis, an honest read of the imaging stage, and a plan that treats the cause of joint shear rather than only the pain. Patients in New York City and Salt Lake City can review our joint, back and orthopedic services or book a consultation to discuss whether regenerative treatment is appropriate for your stage. You can also browse the rest of our blog for related articles on PRP, tendon healing, and hand and wrist conditions, or learn more about our practice and philosophy.

---

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Regenerative therapies including PRP and cell-based treatments are not FDA-approved for the treatment of osteoarthritis, and individual results vary. Do not start, stop, or change any treatment based on this article. Consult a qualified physician about your specific condition. Dr. Ajit Dhaliwal, Regen Health Physicians — New York City and Salt Lake City.